Open mobile menu
Model.SiteSettings!.GetInTouchLink!.Name Contact Us
Jroberts Jruaux Dpingstone 03 B012378 CROPPED
Insights

News

Stay up to date with news about Secerna and intellectual property topics.

VENCLEXTA®

A to Z: Drugs in Highlight: V is for VENCLEXTA®

News A to Z Feature 30/04/2025

Our A to Z series highlights VENCLEXTA® (venetoclax) from AbbVie, a medication used to treat both chronic lymphocytic leukaemia (CLL) and acute myeloid leukaemia (AML). This article explores its mechanism of action, clinical applications, and the patent protection surrounding this important drug.

Read more
Secerna Website Images 2025 (5)
Events, News 17/02/2025

Secerna LLP are presenting at NEPIC Pharma Connect 2025

Secerna Website Images 2025 (6)
Events, News 14/02/2025

Secerna attending Agri-Tech Expo North

KALYDECO
News, A to Z Feature 13/02/2025

A to Z: Drugs in Highlight: K is for KALYDECO®

Protect Your Global Brand Essential Trade Mark Services (1)
News 11/02/2025

Protect Your Global Brand: Essential Trade Mark Services

J Is For JANUVIA®  (1)
News, A to Z Feature 06/02/2025

A to Z: Drugs in Highlight: J is for JANUVIA®

EU FLAG Canva
Industry news, News 03/02/2025

UPC finds infringement by way of equivalence for the first time

IMBRUVICA
News, A to Z Feature 30/01/2025

A to Z: Drugs in Highlight: I is for IMBRUVICA®

Secerna Website Images 2025 (4)
Industry news, News 27/01/2025

Unlocking Faster Cancer Treatments: The Power of Project Orbis

Secerna Website Images 2025 (3)
Industry news, News, Team news 24/01/2025

Secerna Expands Life Sciences Team with the Addition of Trainee Patent Attorney

1 2 3 4 5 6 7 8 9